Prospective User Study and Multicenter Validation of Multimodal Medical Imaging Large Models

Prospective User Study and Multicenter Validation of Multimodal Medical Imaging Large Models in the Diagnosis of Common Systemic Diseases

Following model development and locking, the fixed model is evaluated in prospectively collected CT cohorts from two centers. The study is observational and does not affect clinical care. A subset of cases is used in a randomized crossover reader study.

Study Overview

Detailed Description

After model locking, CT data are prospectively collected at two centers for observational validation without retraining or parameter adjustment. Model outputs do not influence patient management. A subset of eligible cases is selected for the randomized crossover reader study.

Study Type

Observational

Enrollment (Actual)

310

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510630
        • The Third Affiliated Hospital of Southern Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Patients from multiple medical centers in China who underwent systemic CT imaging for various clinical indications, representing a broad range of common systemic diseases.

Description

Inclusion Criteria:

  • Patients who underwent CT examinations for common systemic diseases.
  • Imaging data must have confirmed clinical reference standards, expert consensus, or pathological diagnosis.
  • Availability of complete DICOM format images with standard acquisition protocols.

Exclusion Criteria:

  • Poor image quality (e.g., severe motion or metal artifacts) that precludes definitive diagnosis.
  • Cases with incomplete clinical or pathological reference standards.
  • Corrupted image files or duplicate cases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Validation Cohort
Prospective Observational Validation Cohorts CT data are prospectively collected at two centers after model locking and used for observational model validation. A subset is included in the randomized crossover reader study.
Radiologists interpret the medical images independently without any assistance from the AI model to establish a baseline performance.
Radiologists interpret the same set of medical images with the assistance of the multimodal medical imaging large model to evaluate the improvement in diagnostic performance.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Case-level Diagnostic Accuracy and Area Under the ROC Curve (AUC)
Time Frame: Up to 1 week per evaluation period
Evaluation of case-level diagnostic accuracy (defined as the proportion of diagnostic decisions matching the clinical ground-truth label) and discrimination performance (measured by AUC) to compare unaided radiologist performance versus AI-assisted performance.
Up to 1 week per evaluation period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnostic Efficiency (Reading and Reporting Time)
Time Frame: Up to 1 week per evaluation period
Measurement of diagnostic efficiency recorded as the time (in seconds) taken by radiologists to complete the case review and generate findings, with and without AI assistance.
Up to 1 week per evaluation period
Inter-rater Agreement (Fleiss' Kappa)
Time Frame: Up to 1 week per evaluation period
Assessment of diagnostic consensus and inter-rater consistency among participating radiologists measured using Fleiss' kappa (κ).
Up to 1 week per evaluation period
Clinical Report Quality and Semantic Accuracy Score
Time Frame: Up to 1 week per evaluation period
Assessment of AI-generated draft report quality evaluated by senior experts on a 5-point Likert scale (focusing on semantic accuracy and clinical relevance) and automated metrics (GREEN and ROUGE-L).
Up to 1 week per evaluation period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yinghua Zhao, PhD, The Third Affiliated Hospital of Southern Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2026

Primary Completion (Actual)

June 8, 2026

Study Completion (Actual)

July 10, 2026

Study Registration Dates

First Submitted

April 21, 2026

First Submitted That Met QC Criteria

April 21, 2026

First Posted (Actual)

April 28, 2026

Study Record Updates

Last Update Posted (Actual)

August 7, 2026

Last Update Submitted That Met QC Criteria

August 4, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

To protect patient privacy and comply with institutional data security regulations.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe